Managing Mood Stabilizers in Renal and Hepatic Diseases

The management of mood-stabilizing drugs for patients with renal and/or hepatic disease is similar to a teeter-totter: a balancing act for psychiatric pharmacists, experts said at the AAPP 2025 Annual Meeting.